A 20-marker blood panel for people using GLP-1 weight-loss medication, checking kidney, liver, cholesterol, blood sugar and pancreatic markers.
20 biomarkers as listed by London Medical Laboratory.
This panel is built around monitoring the effects of GLP-1 weight-loss medication rather than diagnosing anything on its own. Kidney markers such as creatinine, urea and eGFR are commonly used to keep an eye on hydration and kidney function, which rapid weight loss can affect. Liver markers matter because the liver processes these medications, a cholesterol profile helps track cardiovascular risk as weight changes, HbA1c reflects longer-term blood sugar control, and amylase and lipase are commonly used to monitor pancreatic enzyme levels.
There is no named comparison group on record for this test, so it is scored against similarly sized metabolism tests we track. On that basis its 20 markers place it around the 57th percentile for depth, and its £99 price sits about 24% below the £129.75 median for that group.
Collection convenience is limited to a clinic venous draw or paid home visit, and trust signals reflect the provider's CQC registration and doctor-reviewed report as standard.
This is aimed at people currently using, or planning to start, GLP-1 weight-loss medication who want to keep track of organ function alongside treatment, ideally as advised by a GP or specialist. It is not designed as a general weight-management check for people not on this type of medication.
This is a blood test taken by venous draw at a partner clinic (£35) or a phlebotomist home visit (£80); it is not available as an at-home finger-prick kit. Results are typically back within a day and are reviewed by a doctor.
This £99 panel checks 20 biomarkers relevant to people on GLP-1 medications such as Mounjaro or Ozempic, pricing about 24% below the £129.75 median for similarly sized metabolism tests we track. It requires a venous blood draw rather than a finger-prick sample.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
20 biomarkers, placing it in the 57th percentile of metabolism tests we track.
A finger-prick sample you take at home; with a venous or clinic option as well; results in around 1 days, well ahead of the metabolism norm of 5.
Results are reviewed by a doctor; the provider does not describe the report format.
No Trustpilot rating on record; CQC registered; doctor review as standard.
£99.00 against a median of £129.75 for the 14 similarly sized metabolism tests we track (-24%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Mid-depth metabolic panel priced well below peers
Measures 19 markers of blood sugar, cholesterol, liver, kidney and inflammation to give a broad view of metabolic health.
Below-median price for a single-marker uric acid test
A single-marker blood test measuring uric acid, used to help monitor gout risk and related joint, kidney and metabolic health.
21-marker Dulaglutide monitoring panel
A 21-marker blood panel that checks kidney function, liver function, cholesterol, blood sugar (HbA1c) and pancreas health, aimed at people taking the GLP-1 medication Dulaglutide (Trulicity). Suits ongoing monitoring rather than a first general health check.
21-marker monitoring panel for Saxenda users
A 21-marker blood panel covering kidney, liver, lipid and blood sugar markers plus lipase, aimed at people taking daily injectable liraglutide (Saxenda) who want to monitor how their body is responding over time.
